tiprankstipranks
Trending News
More News >
RaQualia Pharma Inc. (JP:4579)
:4579
Japanese Market

RaQualia Pharma Inc. (4579) Financial Statements

Compare
1 Followers

RaQualia Pharma Inc. Financial Overview

RaQualia Pharma Inc.'s market cap is currently ¥24.92B. The company's EPS TTM is ¥-8.8; its P/E ratio is -32.45; RaQualia Pharma Inc. is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 3.11B¥ 1.90B¥ 2.92B¥ 2.78B¥ 1.11B
Gross Profit¥ 2.48B¥ 1.66B¥ 2.69B¥ 2.46B¥ 969.29M
Operating Income¥ -213.38M¥ -337.37M¥ 866.24M¥ 707.86M¥ -486.08M
EBITDA¥ 188.27M¥ -111.80M¥ 1.00B¥ 1.02B¥ -403.25M
Net Income¥ -495.03M¥ -323.66M¥ 723.39M¥ 755.79M¥ -606.99M
Balance Sheet
Cash & Short-Term Investments¥ 3.34B¥ 3.76B¥ 3.93B¥ 2.66B¥ 2.11B
Total Assets¥ 9.66B¥ 6.87B¥ 6.26B¥ 5.23B¥ 4.25B
Total Debt¥ 3.45B¥ 367.72M¥ 222.34M¥ 39.07M¥ 45.52M
Net Debt¥ 310.40M¥ -3.35B¥ -3.45B¥ -2.31B¥ -1.35B
Total Liabilities¥ 4.08B¥ 752.00M¥ 760.67M¥ 446.19M¥ 240.11M
Stockholders' Equity¥ 5.57B¥ 6.12B¥ 5.50B¥ 4.79B¥ 4.01B
Cash Flow
Free Cash Flow¥ 84.24M¥ -940.80M¥ 1.45B¥ 260.61M¥ -445.56M
Operating Cash Flow¥ 180.94M¥ -718.60M¥ 1.48B¥ 366.03M¥ -289.21M
Investing Cash Flow¥ -3.67B¥ -135.37M¥ -47.65M¥ -279.25M¥ 225.47M
Financing Cash Flow¥ 2.98B¥ 793.45M¥ -29.56M¥ -16.44M¥ -6.96M
Currency in JPY

RaQualia Pharma Inc. Earnings and Revenue History

RaQualia Pharma Inc. Debt to Assets

RaQualia Pharma Inc. Cash Flow

RaQualia Pharma Inc. Forecast EPS vs Actual EPS